Nuveen »

Sionna Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2025-09-30 $472k 16k 29.41
2025-06-30 $278k 16k 17.35

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Nuveen

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Atlas Venture Life Science Advisors
Viking Global Investors
Enavate Sciences GP
Jpmorgan Chase & Co
Perceptive Advisors
Vanguard Group
Jennison Associates
Deerfield Management Company
Standard Life Aberdeen
BlackRock
Soleus Capital Management
Baker Bros. Advisors

View all funds holding Sionna Therapeutics